XML 45 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Goodwill and Other Intangible Assets Goodwill (Tables)
9 Months Ended
Sep. 30, 2015
Note D - Goodwill and Other Intangible Assets [Abstract]  
Goodwill
The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill as of September 30, 2015 and December 31, 2014 are as follows:
 
As of
 
September 30, 2015
 
December 31, 2014
 
Gross Carrying
 
Accumulated
Amortization/
 
Gross Carrying
 
Accumulated
Amortization/
(in millions)
Amount
 
Write-offs
 
Amount
 
Write-offs
Amortizable intangible assets
 
 
 
 
 
 
 
Technology-related
$
8,874

 
$
(3,952
)
 
$
8,406

 
$
(3,697
)
Patents
519

 
(354
)
 
519

 
(342
)
Other intangible assets
1,512

 
(584
)
 
875

 
(533
)
 
$
10,905

 
$
(4,890
)
 
$
9,800

 
$
(4,572
)
Unamortizable intangible assets
 
 
 
 
 
 
 
Goodwill
$
16,368

 
$
(9,900
)
 
$
15,798

 
$
(9,900
)
In-process research and development (IPR&D)
93

 

 
181

 

Technology-related
120

 

 
197

 

 
$
16,581

 
$
(9,900
)
 
$
16,176

 
$
(9,900
)
Schedule of Goodwill [Table Text Block]
The following is a rollforward of accumulated goodwill write-offs by global reportable segment:
(in millions)
Cardiovascular
 
Rhythm Management
 
MedSurg
 
Total
Accumulated write-offs as of December 31, 2014
$
(1,479
)
 
$
(6,960
)
 
$
(1,461
)
 
$
(9,900
)
Goodwill written off

 

 

 

Accumulated write-offs as of September 30, 2015
$
(1,479
)
 
$
(6,960
)
 
$
(1,461
)
 
$
(9,900
)
The following represents our goodwill balance by global reportable segment:
(in millions)
Cardiovascular
 
Rhythm Management
 
MedSurg
 
Total
Balance as of December 31, 2014
$
3,426

 
$
290

 
$
2,182

 
$
5,898

Purchase price adjustments

 
2

 

 
2

Goodwill acquired

 

 
568

 
568

Balance as of September 30, 2015
$
3,426

 
$
292

 
$
2,750

 
$
6,468

Description of unobservable inputs used in Level 3 fair value measurements [Table Text Block]
The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs:
Contingent Consideration Liability
Fair Value as of September 30, 2015
Valuation Technique
Unobservable Input
Range
Revenue-based Payments
$84 million
Probability Weighted Discounted Cash Flow
Discount Rate
11.5% - 15%
Projected Year of Payment
2015 - 2019
$182 million
Monte Carlo
Revenue Volatility
11% - 20%
Risk Free Rate
LIBOR Term Structure
Projected Year of Payment
2015 - 2018
The nonrecurring Level 3 fair value measurements of our intangible asset impairment analysis included the following significant unobservable inputs:
Intangible Asset
Valuation Date
Fair Value
Valuation Technique
Unobservable Input
Rate
Core Technology
September 30, 2015
$8 million
Income Approach -Excess Earnings Method
Discount Rate
10%
In-Process R&D
June 30, 2015
$6 million
Income Approach - Excess Earnings Method
Discount Rate
 16.5 - 20%
In-Process R&D
September 30, 2014
$16 million
Income Approach - Excess Earnings Method
Discount Rate
 16.5 - 20%
In-Process R&D
June 30, 2014
$83 million
Income Approach - Excess Earnings Method
Discount Rate
 16.5 - 20%
Core Technology
June 30, 2014
$8 million
Income Approach - Excess Earnings Method
Discount Rate
15%
In-Process R&D
March 31, 2014
$6 million
Income Approach - Excess Earnings Method
Discount Rate
20%
Core Technology
March 31, 2014
$64 million
Income Approach - Excess Earnings Method
Discount Rate
15%